Shevaun Haviland

THE WRITER IS DIRECTOR GENERAL OF THE BRITISH CHAMBERS OF COMMERCE

Life sciences is an ideal sector for the UK and Singapore to pilot a trade accelerator. The UK brings world-leading research, clinical expertise and a pipeline of companies while Singapore brings a sophisticated regulatory environment, deep capital markets and a strong biomedical ecosystem.

Trade deals open doors. Someone still has to walk through them

2026-09-07T23:00:00.000Z